Enobia Pharma News
Most Popular Enobia Pharma Story
Emerging Drug Developer: Enobia
Last fall, Enobia’s chief executive concluded that the small biotech company needed a new direction. Its longtime lead program, an enzyme replacement therapy for X-linked hypophosphatemia, or XLH, Read more...
Latest Headlines
- August 10, 2011
- August 10, 2009
- May 22, 2009
- September 13, 2007
- September 11, 2007
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
